• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,571.74 940.09
( 1.23%)
Global Indices
Nasdaq
48,208.69 277.76
(0.58%)
Dow Jones
6,845.97 42.16
(0.62%)
Hang Seng
56,916.27 1,020.95
(1.83%)
Nikkei 225
10,579.52 -29.36
(-0.28%)
Forex
USD-INR
92.44 -0.46
(-0.50%)
EUR-INR
107.96 0.52
(0.48%)
GBP-INR
124.05 0.88
(0.72%)
JPY-INR
0.58 0.00
(0.32%)

EQUITY - MARKET SCREENER

Aarey Drugs & Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524412
INE198H01019
51.1335451
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AAREYDRUGS
54.28
186.23
EPS(TTM)
Face Value()
Div & Yield %
1.21
10
0
 

Indian Bank jumps as total deposits climb 13% YoY to Rs 7.90 lakh crore in Q3
Jan 02,2026
Gross advances increased 14.5% to Rs 6.40 lakh crore as of 31 December 2025 as against Rs 5.59 lakh crore as of 31 December 2024.

The bank’s total business grew 13.4% to Rs 14.30 lakh crore as of 31 December 2025 as against Rs 12.61 lakh crore as of 31 December 2024.

CASA deposits rose 19.4% year on year (YoY) to Rs 0.43 lakh crore as of 31 December 2025. However, the CASA (domestic) ratio moderated to 39.02%, compared with 40% in the corresponding period last year.

Indian Bank has many deposit schemes tailored to suit the needs of its customers, both individuals and organizations. Credit/advances/loan schemes specifically designed for its customers. Also, it offers various novel services to customers, both individuals and organizations.

The bank reported an 11.51% increase in standalone net profit to Rs 3,018.22 crore in Q2 FY26, compared to Rs 2,706.44 crore in Q2 FY25. Total income rose 7.35% YoY to Rs 19,076.57 crore in the quarter ended 30 September 2025.